2015 | The Wall Street Analyzer

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:EDUC […]

Featured Interviews

FingerMotion, Inc (NASDAQ: FNGR)

July 18, 2024 0

ABOUT: FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China.As the user base of its primary business continues to grow, the Company is developing additional value-added technologies to market to its users. The vision of the Company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the Company to onboard larger customer bases. FingerMotion eventually hopes to serve over 1 billion users in the China market and eventually expand the model to other regional markets. For more information on FingerMotion, visit: https://fingermotion.com/ […]

CEO Interviews

Peer To Peer Network (OTC: PTOP)

July 11, 2024 0

Interview with Josh Soditas, CEO We spoke to Josh following the company’s most recent announcement on July 1st:

Year: 2015

MCW Energy Group Limited (TSXV:MCW) (OTCQX:MCWEF) CEO: Dr. Jerry Bailey

GlobalSCAPE, Inc (NYSE:GSB) CEO interview

Epicore BioNetworks (TSX-V: EBN) CEO: Bill Long

STAG Industrial, Inc. (NYSE: STAG) CEO Interview

DataWind Inc. (TSX: DW) Management Interview

UPDATE: Equities.com Publishes Video Interview about Immune Pharmaceuticals Financing

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

Prodex, Inc (NASDAQ: PDEX)

Client Testimonials: